REVIVE THERAPEUTICS has a Market Capitalization of only 27.158M, while the Net Income (FY) reveals a debt, -1.028M.
Some analists predict an Average Target Price of 2.36 usd.
The indicators are bullish on most timeframes.
Still a lot of room to grow, with that huge volume.
If you are interested to test some amazing buy and sell indicators, which give the signal...
